Last reviewed · How we verify
insulin glulisin / insulin detemir
insulin glulisin / insulin detemir is a insulin analog Small molecule drug developed by Sanofi. It is currently in Phase 3 development for Type 1 diabetes, Type 2 diabetes.
Insulin glulisine and insulin detemir work together to lower blood sugar levels by stimulating the uptake of glucose by cells.
Insulin glulisine and insulin detemir work together to lower blood sugar levels by stimulating the uptake of glucose by cells. Used for Type 1 diabetes, Type 2 diabetes.
At a glance
| Generic name | insulin glulisin / insulin detemir |
|---|---|
| Sponsor | Sanofi |
| Drug class | insulin analog |
| Target | insulin receptor |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
Insulin glulisine is a rapid-acting insulin analog that starts working within 15 minutes of injection, while insulin detemir is a long-acting insulin analog that provides a steady level of insulin in the body for up to 24 hours. Together, they help to control blood sugar levels throughout the day and night.
Approved indications
- Type 1 diabetes
- Type 2 diabetes
Common side effects
- Hypoglycemia
- Weight gain
- Allergic reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- insulin glulisin / insulin detemir CI brief — competitive landscape report
- insulin glulisin / insulin detemir updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about insulin glulisin / insulin detemir
What is insulin glulisin / insulin detemir?
How does insulin glulisin / insulin detemir work?
What is insulin glulisin / insulin detemir used for?
Who makes insulin glulisin / insulin detemir?
What drug class is insulin glulisin / insulin detemir in?
What development phase is insulin glulisin / insulin detemir in?
What are the side effects of insulin glulisin / insulin detemir?
What does insulin glulisin / insulin detemir target?
Related
- Drug class: All insulin analog drugs
- Target: All drugs targeting insulin receptor
- Manufacturer: Sanofi — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 1 diabetes
- Indication: Drugs for Type 2 diabetes
- Compare: insulin glulisin / insulin detemir vs similar drugs
- Pricing: insulin glulisin / insulin detemir cost, discount & access